Clinical TrialsSearch results
Number of results: 204
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Phase II study of Neoadjuvant chemotherapy with Gemcitabine and S1 (GS therapy) for resectable pancreatic carcinoma
- resectable pancreatic cancer
- Department of surgery, Tohoku University
- 2008-11-13
Other
- Phase II study of micafungin as empirical antifungal therapy for febrile neutropenic patients (C-SHOT 0503 study)
- Febrile neutropenia
- Center for Supporting Hematology-Oncology Trials (C-SHOT)
- 2006-03-30
Other
- Phase II study of imatinib mesylate for treatment of Philadelphia Chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in children: A Japanese Cooperative Trial
- Philadelphia Chromosome-positive acute lymphoblastic leukemia
- Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)
- 2005-12-01
Other
- Phase II study of cord blood transplantation using myeloablative conditioning in adult patiants (C-SHOT 0603)
- Acute leukemia, Chronic myelogenous leukemia, Myelodysplastic syndrome
- Research Grant on Tissue Engineering from the Japanese Ministry of Health, Labor & Welfare
- 2007-10-29
Other
- Phase II study of combination chemotherapy and high-dose chemotherapy in treating young children with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumors
- medulloblastoma or supratentorial primitive neuroectodermal tumors
- Japanese Pediatric Brain Tumor Consortium
- 2006-12-08
Other
- Phase II study of Chemotherapy for Advanced or Recurrent Thymoma
- Thymoma (excluding thymic carcinoma)
- Japanese Association for Research on the Thymus
- 2006-04-01
Other
- Phase II study of amrubicin combined with carboplatin for unresectable invasive thymoma or thymic carcinoma
- Thymoma/Thymic carcinoma
- Tohoku University Hospital
- 2010-03-31
Other
- Phase II study of amrubicin combined with carboplatin for refractory relapsed small-cell lung cancer
- Small-cell lung cancer
- Tohoku University Hospital
- 2010-03-31
Other
- Phase II study of ABVd therapy for the previously untreated patients with stage II to IV Hodgkin' s disease (JCOG 9305, LSG14)
- previouly untreated advanced stage Hodgkin lymphoma (stage II, III, IVy)
- Japan Clinical Oncology Group(JCOG)
- 2005-08-30
Other
- Phase II study of ABV with increased dose of adriamycin (ADM) and deleted DTIC followed by adjuvant involved-field radiotherapy (ABV/IFRT) to residual or initial bulky tumor for the previously untreated patients with advanced Hodgkin's disease (stage IB, IIB, III, IV or bulky). (JCOG9705)
- previouly untreated advanced stage Hodgkin lymphoma (stage IB, IIB, III, IV, or bulky)
- Japan Clinical Oncology Group(JCOG)
- 2005-08-18